Stay updated on Efficacy of MTPS9579A in Asthma Patients: Clinical Trial
Sign up to get notified when there's something new on the Efficacy of MTPS9579A in Asthma Patients: Clinical Trial page.

Latest updates to the Efficacy of MTPS9579A in Asthma Patients: Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision note updated to v3.4.2, and the previous notification about government funding status (v3.4.1) was removed; these are administrative updates that do not alter study content, endpoints, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding notice about potential delays and updated the revision banner to v3.4.1, with the previous v3.4.0 banner removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a glossary toggle and new metadata labels: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Replaced the old labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no user-facing study content or functionality appears to be affected.SummaryDifference0.0%

- Check84 days agoChange DetectedA top-level Locations section was added and state-level location subsections (California, Florida, Ohio, Oklahoma, Pennsylvania, South Carolina) were removed, reorganizing how sites are displayed. Revision: v3.3.3.SummaryDifference0.6%

Stay in the know with updates to Efficacy of MTPS9579A in Asthma Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of MTPS9579A in Asthma Patients: Clinical Trial page.